Ocrevus 300 MG/10 ML vial 10ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM8ER
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,638
Award facts
- Contract value 100% obligated
- $25,637.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $25,637.70 delivery order to Amerisourcebergen Drug Corp on April 9, 2026, for Ocrevus 300 mg/10 mL vials under a firm fixed-price arrangement. Ultimate completion date is April 30, 2026. Place of performance is Conshohocken, PA.
The order is issued under the DLA Troop Support Medical indefinite delivery contract (SPE2DX), a $999,999,999 vehicle through December 2026 supporting global pharmaceutical supply for military healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FM8ER?
SPE2DR26FM8ER was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 9, 2026.
How much is contract SPE2DR26FM8ER worth?
The government has obligated $25,638 on SPE2DR26FM8ER.
Is contract SPE2DR26FM8ER an order under another contract?
Yes. SPE2DR26FM8ER is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM8ER competed?
The extent of competition for SPE2DR26FM8ER was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award